Vericel Corporation (VCEL): Price and Financial Metrics


Vericel Corporation (VCEL): $23.85

0.80 (+3.47%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add VCEL to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

VCEL POWR Grades

  • Quality is the dimension where VCEL ranks best; there it ranks ahead of 67.44% of US stocks.
  • The strongest trend for VCEL is in Stability, which has been heading up over the past 179 days.
  • VCEL's current lowest rank is in the Sentiment metric (where it is better than 0.28% of US stocks).

VCEL Stock Summary

  • Price to trailing twelve month operating cash flow for VCEL is currently 46.84, higher than 90.75% of US stocks with positive operating cash flow.
  • With a price/sales ratio of 6.25, VERICEL CORP has a higher such ratio than 82.54% of stocks in our set.
  • Over the past twelve months, VCEL has reported earnings growth of -3,078.3%, putting it ahead of only 0.42% of US stocks in our set.
  • If you're looking for stocks that are quantitatively similar to VERICEL CORP, a group of peers worth examining would be YOU, MQ, DKNG, PATH, and FCUV.
  • Visit VCEL's SEC page to see the company's official filings. To visit the company's web site, go to vcel.com.

VCEL Valuation Summary

  • VCEL's EV/EBIT ratio is -54.6; this is 734.88% lower than that of the median Healthcare stock.
  • VCEL's price/sales ratio has moved down 23.4 over the prior 243 months.

Below are key valuation metrics over time for VCEL.

Stock Date P/S P/B P/E EV/EBIT
VCEL 2022-11-25 6.4 5.7 -56.0 -54.6
VCEL 2022-11-23 6.4 5.7 -56.0 -54.5
VCEL 2022-11-22 6.4 5.7 -56.1 -54.6
VCEL 2022-11-21 6.3 5.7 -55.6 -54.2
VCEL 2022-11-18 6.3 5.7 -55.6 -54.1
VCEL 2022-11-17 6.2 5.6 -55.0 -53.6

VCEL Growth Metrics

    Its 4 year price growth rate is now at 455.09%.
  • The 4 year revenue growth rate now stands at 125.66%.
  • Its 2 year price growth rate is now at 96.27%.
VCEL's revenue has moved up $41,412,000 over the prior 33 months.

The table below shows VCEL's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 159.262 21.263 -18.096
2022-06-30 155.217 20.796 -16.45
2022-03-31 157.69 22.422 -11.273
2021-12-31 156.184 29.04 -7.471
2021-09-30 153.822 29.826 0.214
2021-06-30 151.574 30.762 8.763

VCEL's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • VCEL has a Quality Grade of C, ranking ahead of 72.89% of graded US stocks.
  • VCEL's asset turnover comes in at 0.761 -- ranking 35th of 682 Pharmaceutical Products stocks.
  • TCON, NMTR, and PTCT are the stocks whose asset turnover ratios are most correlated with VCEL.

The table below shows VCEL's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.761 0.699 0.052
2021-03-31 0.732 0.685 0.031
2020-12-31 0.753 0.678 0.023
2020-09-30 0.779 0.671 0.001
2020-06-30 0.793 0.670 0.000
2020-03-31 0.866 0.683 -0.094

VCEL Price Target

For more insight on analysts targets of VCEL, see our VCEL price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $65.04 Average Broker Recommendation 1.29 (Strong Buy)

VCEL Stock Price Chart Interactive Chart >

Price chart for VCEL

VCEL Price/Volume Stats

Current price $23.85 52-week high $43.97
Prev. close $23.05 52-week low $17.30
Day low $22.21 Volume 273,800
Day high $24.24 Avg. volume 484,067
50-day MA $23.71 Dividend yield N/A
200-day MA $28.60 Market Cap 1.13B

Vericel Corporation (VCEL) Company Bio


Vericel Corporation focuses on developing patient-specific expanded cellular therapies for use in the treatment of patients with severe diseases and conditions. The company was founded in 1989 and is based in Cambridge, Massachusetts.


VCEL Latest News Stream


Event/Time News Detail
Loading, please wait...

VCEL Latest Social Stream


Loading social stream, please wait...

View Full VCEL Social Stream

Latest VCEL News From Around the Web

Below are the latest news stories about VERICEL CORP that investors may wish to consider to help them evaluate VCEL as an investment opportunity.

Do investors need to be concerned about Vericel Corporation (VCEL)?

The share price of Vericel Corporation (NASDAQ:VCEL) rose to $23.28 per share on Tuesday from $23.09. While Vericel Corporation has overperformed by 0.82%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, VCEL fell by -43.69%, with highs and lows ranging from $46.30 to $17.30, whereas the […]

US Post News | November 16, 2022

Vericel Third Quarter 2022 Earnings: Misses Expectations

Vericel ( NASDAQ:VCEL ) Third Quarter 2022 Results Key Financial Results Revenue: US$38.6m (up 12% from 3Q 2021). Net...

Yahoo | November 11, 2022

Vericel to Participate in the Canaccord Genuity MedTech, Diagnostics, and Digital Health & Service Forum and the Stephens Annual Investment Conference

CAMBRIDGE, Mass., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Company leadership will present at the upcoming Canaccord Genuity MedTech, Diagnostics, and Digital Health & Service Forum and the Stephens Annual Investment Conference. Nick Colangelo, President and CEO will present at the CG MedTech, Diagnostics, and Digital Health & Service Forum at 10:00 a.m. ET on Thu

Yahoo | November 10, 2022

BTIG downgrades Vericel (VCEL) to a Hold

E ratio of -64.75.

Jason Carr on TipRanks | November 9, 2022

Vericel Reports Third Quarter 2022 Financial Results

Total Net Product Revenue of $38.6 Million

GlobeNewswire | November 9, 2022

Read More 'VCEL' Stories Here

VCEL Price Returns

1-mo -10.07%
3-mo 5.11%
6-mo -9.83%
1-year -33.12%
3-year 27.10%
5-year 391.75%
YTD -39.31%
2021 27.27%
2020 77.47%
2019 0.00%
2018 219.27%
2017 81.67%

Continue Researching VCEL

Here are a few links from around the web to help you further your research on Vericel Corp's stock as an investment opportunity:

Vericel Corp (VCEL) Stock Price | Nasdaq
Vericel Corp (VCEL) Stock Quote, History and News - Yahoo Finance
Vericel Corp (VCEL) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6882 seconds.